Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 6;10(10):3661-3663.
doi: 10.1016/j.ekir.2025.07.043. eCollection 2025 Oct.

Sensitivity of Enzyme-Linked Immunosorbent Assay in Monitoring Treatment Response in Phospholipase A2 Receptor -Associated Membranous Nephropathy

Coralien Vink  1 , Ruben Visch  1 , Jack Wetzels  1 , Anne-Els van de Logt  1
Affiliations

Sensitivity of Enzyme-Linked Immunosorbent Assay in Monitoring Treatment Response in Phospholipase A2 Receptor -Associated Membranous Nephropathy

Coralien Vink et al. Kidney Int Rep. .
No abstract available

Keywords: M-type phospholipase A2 receptor; enzyme-linked immunosorbent assay; immunofluorescence test; membranous nephropathy.

PubMed Disclaimer

References

    1. Beck L.H., Jr., Bonegio R.G., Lambeau G., et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21. doi: 10.1056/NEJMoa0810457. - DOI - PMC - PubMed
    1. Hoxha E., Harendza S., Zahner G., et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26:2526–2532. doi: 10.1093/ndt/gfr247. - DOI - PubMed
    1. Dahnrich C., Komorowski L., Probst C., et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta. 2013;421:213–218. doi: 10.1016/j.cca.2013.03.015. - DOI - PubMed
    1. Rovin B.H., Adler S.G., Barratt J., et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100:753–779. doi: 10.1016/j.kint.2021.05.015. - DOI - PubMed
    1. Vink C.H., van de Logt A.E., van der Molen R.G., Hofstra J.M., Wetzels J.F. Antibody-guided therapy in Phospholipase A2 receptor-associated membranous nephropathy. Kidney Int Rep. 2022;8:432–441. doi: 10.1016/j.ekir.2022.12.003. - DOI - PMC - PubMed

LinkOut - more resources